In advance of the planned spinoff of generics subsidiary Sandoz into a standalone generics producer, Novartis has announced it is closing one of the subsidiary’s US...
08.04.2020
- In early March, the Indian government asserted that the coronavirus epidemic in China was affecting its supply of active pharmaceutical ingredients (APIs), on which it relies for...
10.01.2019
- Each year in March, the pharmaceutical manufacturing industry gathers in New York City for DCAT Week, and this year is no exception. DCAT Week ’19, the flagship event of the Drug...
23.08.2018
- After two years of trying, Israeli generics producer Teva Pharmaceutical Industries has finally gained approval by the US Food and Drug Administration (FDA) for its copy of Mylan’s...
12.07.2018
- French drugmaker Sanofi and private equity investor Advent International have agreed a deal under which Advent will acquire Sanofi's European generics business Zentiva for €1.9...
09.04.2018
- The Chinese government has announced a new pharmaceutical policy that will include tax breaks to promote generics, allow compulsory patent licensing during public health...
12.02.2018
- Troubled Israeli generics giant Teva Pharmaceuticals is making "strong progress" on its turnaround plan, despite an even higher loss – approaching $12 billion – in the 2017 fourth...
